The present work was concentrated mainly on the reaction processes of boro/carbothermal reduction (BCTR) of ZrO 2 with B 4 C and carbon in vacuum, and characterization of morphology and sinterability of the obtained ZrB 2 powder. Combining the thermodynamic calculations, X-ray diffraction results, and the trend of furnace pressure with temperature during synthesis, a detailed explanation of the reaction processes of BCTR was developed. Most of the ZrB 2 particles obtained at 16501C presented a nearly spherical morphology, whereas those synthesized at 17501C showed a nearly columnar morphology with an increased size. Compared with the powder synthesized at 17501C as well as the commercially additive-free powder used in the reported work, the ZrB 2 powder synthesized at 16501C showed a better sinterability due to its smaller particle size and lower oxygen content.
The ZrB2 powders with submicrometric particle size and low oxygen content were synthesized by a new borothermal reduction route using ZrO2 and excess boron as raw materials. The conventional process only contained the borothermal reduction of ZrO2 with boron at 1550°C. By exploring the mechanism of ZrB2 particle coarsening during conventional process, a new borothermal reduction route was proposed. This route included the borothermal reduction of ZrO2 with boron at 1000°C, washing by hot water, and the removal of residual boron oxides at 1550°C, namely, two‐step reduction plus intermediate water‐washing (RWR). Using conventional process, the particle size and oxygen content of ZrB2 powder were about 2–3 μm and 0.68 wt%, respectively. Based on the new route, the particle size and oxygen content of ZrB2 powder were about 0.4–0.7 μm and 0.40 wt%, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.